Literature DB >> 27256886

"The More I Do, the Better I'll Be": The Treatment Preferences of Type 2 Diabetes Among African American Men.

Ledric D Sherman1, Taliat Fawole1.   

Abstract

To gain better insight to the preferred methods of managing and treating type 2 diabetes among African American men (AA men). Participants ( n = 19) were AA men aged 35 to 69 years, who were diagnosed with type 2 diabetes. Participants were recruited via community outreach efforts, including barbershops and churches located in predominantly African American communities in Southeast United States. On consent, individual interviews were conducted, audio recorded, and subsequently transcribed. Transcripts were analyzed using a phenomenological approach, and focused on identifying common themes among the descriptions of AA men's experiences specific to type 2 diabetes. Participants' statements indicated three main commonalities regarding treatment preferences which were medication, dietary changes, and increase in exercise. Some participants from the study stated that they preferred taking oral medication primarily out of convenience, lack of pain, and how well the medicine makes them feel. Others stated educating themselves and having a consistent relationship with the diabetes physician has assisted them the most. Other participants shared preferences of being dedicated to proper diet and exercise without any medication (pill or injection), as well as maintaining the mental motivation needed to sustain management. Some participants preferred to not take an oral pill, while some did not mind taking pills at all. For some of the participants, it appears that it is easier for them to manage their diabetes by prescription medication than by lifestyle changes such as diet and exercise. Future studies are needed to investigate how social support system also assists these men in managing their diabetes.

Entities:  

Keywords:  African American men; self-management; treatment; type 2 diabetes

Mesh:

Year:  2016        PMID: 27256886      PMCID: PMC6131424          DOI: 10.1177/1557988316642274

Source DB:  PubMed          Journal:  Am J Mens Health        ISSN: 1557-9883


  19 in total

1.  Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition.

Authors:  Russell E Glasgow; Edward Lichtenstein; Alfred C Marcus
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

2.  Standards of medical care in diabetes--2008.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

3.  Patient priorities and needs for diabetes care among urban African American adults.

Authors:  M L Batts; T L Gary; K Huss; M N Hill; L Bone; F L Brancati
Journal:  Diabetes Educ       Date:  2001 May-Jun       Impact factor: 2.140

4.  Racial and ethnic differences in glycemic control of adults with type 2 diabetes.

Authors:  M I Harris; R C Eastman; C C Cowie; K M Flegal; M S Eberhardt
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

Review 5.  The Family Investigation of Nephropathy and Diabetes (FIND): design and methods.

Authors:  William C Knowler; Josef Coresh; Robert C Elston; Barry I Freedman; Sudha K Iyengar; Paul L Kimmel; Jane M Olson; Rosemarie Plaetke; John R Sedor; Michael F Seldin
Journal:  J Diabetes Complications       Date:  2005 Jan-Feb       Impact factor: 2.852

6.  Exercise preferences and barriers in urban African Americans with type 2 diabetes.

Authors:  Nancy S Wanko; Carol W Brazier; Denine Young-Rogers; Virginia G Dunbar; Barbara Boyd; Christopher D George; Mary K Rhee; Imad M el-Kebbi; Curtiss B Cook
Journal:  Diabetes Educ       Date:  2004 May-Jun       Impact factor: 2.140

7.  Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.

Authors:  Xavier Pi-Sunyer; George Blackburn; Frederick L Brancati; George A Bray; Renee Bright; Jeanne M Clark; Jeffrey M Curtis; Mark A Espeland; John P Foreyt; Kathryn Graves; Steven M Haffner; Barbara Harrison; James O Hill; Edward S Horton; John Jakicic; Robert W Jeffery; Karen C Johnson; Steven Kahn; David E Kelley; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Brenda Montgomery; David M Nathan; Jennifer Patricio; Anne Peters; J Bruce Redmon; Rebecca S Reeves; Donna H Ryan; Monika Safford; Brent Van Dorsten; Thomas A Wadden; Lynne Wagenknecht; Jacqueline Wesche-Thobaben; Rena R Wing; Susan Z Yanovski
Journal:  Diabetes Care       Date:  2007-03-15       Impact factor: 19.112

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Diabetes education for people with disabilities.

Authors: 
Journal:  Diabetes Educ       Date:  2002 Nov-Dec       Impact factor: 2.140

10.  Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes.

Authors:  Elbert S Huang; Sydney E S Brown; Nidhi Thakur; Lisabeth Carlisle; Edward Foley; Bernard Ewigman; David O Meltzer
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.